Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Feb;75(2):73-75.
doi: 10.1136/jclinpath-2021-207967. Epub 2021 Nov 9.

Improved pathology reporting in NAFLD/NASH for clinical trials

Caitlin Rose Langford  1 , Marc H Goldinger  2 , Darren Treanor  3   4 , Clare McGenity  3   4 , Jonathan R Dillman  5   6 , Daniela S Allende  7 , Robert Goldin  8 , Elizabeth M Brunt  9 , Kurt Zatloukal  10 , Helmut Denk  10 , Kenneth A Fleming  2   11
Affiliations

Improved pathology reporting in NAFLD/NASH for clinical trials

Caitlin Rose Langford et al. J Clin Pathol. 2022 Feb.
No abstract available

Keywords: gastrointestinal diseases; liver; liver diseases; research report; safety.

PubMed Disclaimer

Conflict of interest statement

Competing interests: CRL, MHG and KAF are employees of Perspectum. EMB has consulted for Perspectum, Alnylam, Pfizer and Intercept and has been a study pathologist for Cymabay and Medpace.

References

    1. Nobili V, Alisi A, Newton KP, et al. . Comparison of the phenotype and approach to pediatric vs adult patients with nonalcoholic fatty liver disease. Gastroenterology 2016;150:1798–810. 10.1053/j.gastro.2016.03.009 - DOI - PMC - PubMed
    1. Williams CD, Stengel J, Asike MI, et al. . Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study. Gastroenterology 2011;140:124–31. 10.1053/j.gastro.2010.09.038 - DOI - PubMed
    1. Sherif ZA, Saeed A, Ghavimi S, et al. . Global epidemiology of nonalcoholic fatty liver disease and perspectives on us minority populations. Dig Dis Sci 2016;61:1214–25. 10.1007/s10620-016-4143-0 - DOI - PMC - PubMed
    1. Hagström H, Nasr P, Ekstedt M, et al. . Risk for development of severe liver disease in lean patients with nonalcoholic fatty liver disease: a long-term follow-up study. Hepatol Commun 2018;2:48–57. 10.1002/hep4.1124 - DOI - PMC - PubMed
    1. Younossi Z, Stepanova M, Ong JP, et al. . Nonalcoholic steatohepatitis is the fastest growing cause of hepatocellular carcinoma in liver transplant candidates. Clin Gastroenterol Hepatol 2019;17:748–55. 10.1016/j.cgh.2018.05.057 - DOI - PubMed